ARACHIDONATE PRODUCTS IN DIOXIN AND PCB TOXICITY
花生四烯酸产品的二恶英和多氯联苯毒性
基本信息
- 批准号:6839965
- 负责人:
- 金额:$ 46.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-12-01 至 2007-09-29
- 项目状态:已结题
- 来源:
- 关键词:RNase protection assayarachidonatearomatic hydrocarbon receptorcalcium transporting ATPasecardiotoxinchick embryocytochrome P450dioxinseicosanoid metabolismenvironmental toxicologyenzyme activityenzyme induction /repressionfree radical oxygenhalobiphenyl /halotriphenyl compoundheart contractionimmunocytochemistryin situ hybridizationnitric oxide synthasenucleic acid probesphospholipase inhibitorsodium potassium exchanging ATPasetoxin metabolismtransfection
项目摘要
The role of the Ah receptor in the induction of cytochrome P450 (CYP)1A
enzymes by the environmental toxin 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin)is
well understood, but the role of CYP1A in dioxin toxicity is not. In this competing
renewal we will focus on the role of CYP1A induction in the biologic effects of
dioxin. We will continue to use the well characterized chick embryo model whose
many advantages include ease of introducing modified genes in vivo and of
conducting molecular and biochemical studies in primary cell cultures and organs
from the same species. We recently cloned the dioxin-induced CYP1A enzymes
(CYP1A4 and 1A5 vs CYP1A1 and 1A2 in mammals). CYP1A4 is an aryl
hydrocarbon hydroxylase. CYP1A5, like human CYP1A2, is an arachidonic acid
epoxygenase. The ability of CYP1A to metabolize an important endogenous
substrate to biologically active products supports a functional role for CYP1A. We
found also that dioxin induces 1A4 and 1A5 in liver and kidney but CYPIA4 alone
in the heart and-vascular endothelium, that dioxin depresses induction by endotoxin
of the cardiovascular modulator iNOS in liver, and that dioxin is cardiotoxic, These
findings point to the cardiovascular system as a majortargetof dioxin action. We
will testthe hypothesis that CYP1A products, eicosanoids and reactive oxygen
species, modulate effects of dioxin on expression or activity of biologically
significant proteins in cardiovascular function. Unequivocal evidence for CYP1A
involvement will be obtained by exploiting exciting new retroviralmolecular
techniques specifically tailored to the chick and newly developed cDNA probes for
CYP1A4 and 1A5. CYP1A4 and CYP1A5 will be suppressed or superexpressed by
organ specific targetting of antisense or sense constructs in retroviral vectors to
chick embryo heart, liver or kidney in ova in early development and the effects
examined close to hatching. The effects of CYP1A modification on CYP1A4 and
1A5 and two potential cardiovascular targets of dioxin, SERCA and
Na+/K+ATPase will be investigated in SpecificAim 1. The mechanisms by which
dioxin depresses iNOS and impairs cardiac contractile responses and the role of
CYP1A in those effects will be investigated in Specific Aims 2 and 3, respectively.
All three SA will apply the same molecular techniques to modify CYP1A
expression. This research will apply a powerful now technology for organ-specific
gene manipulation to a significant toxicologic issue (CYP1A function) and will
provide insights into important cardiovascular aspects of dioxin toxicity.
Ah受体在细胞色素P450(CYP)1A诱导中的作用
酶的环境毒素2,3,7,8-四氯二苯并-p-二恶英(二恶英)是
CYP 1A在二恶英毒性中的作用尚不清楚。在这场竞争中,
更新,我们将集中在CYP 1A诱导的作用,在生物学效应,
二恶英我们将继续使用良好表征的鸡胚模型,
许多优点包括易于在体内引入修饰的基因,
在原代细胞培养和器官中进行分子和生物化学研究
来自同一物种。我们最近克隆了二恶英诱导的CYP 1A酶
(哺乳动物中的CYP 1A 4和1A 5与CYP 1A 1和1A 2)。CYP 1A 4是芳基
烃羟化酶CYP 1A 5与人CYP 1A 2一样,是一种花生四烯酸,
环氧酶CYP 1A代谢一种重要的内源性
生物活性产物的底物支持CYP 1A的功能作用。我们
还发现二恶英在肝脏和肾脏中诱导1A 4和1A 5,而CYPIA 4单独
在心脏和血管内皮中,二恶英抑制内毒素诱导
心血管调节剂iNOS在肝脏中,二恶英是心脏毒性,这些
研究结果指出,心血管系统是二恶英作用的主要目标。我们
将检验CYP 1A产物、类花生酸和活性氧
物种,调节二恶英对生物学表达或活性的影响,
心血管功能的重要蛋白质。CYP 1A的明确证据
通过开发令人兴奋的新逆转录病毒分子,
专门针对鸡和新开发的cDNA探针的技术,
CYP 1A 4和1A 5。CYP 1A 4和CYP 1A 5将被抑制或超表达,
逆转录病毒载体中反义或有义构建体的器官特异性靶向,
鸡胚心、肝、肾在卵内的早期发育及其影响
检查接近孵化。CYP 1A修饰对CYP 1A 4和
1A 5和二恶英的两个潜在心血管靶点SERCA和
将在SpecificAim 1中研究Na+/K+ ATP酶。的机制
二恶英抑制iNOS并损害心脏收缩反应,
将分别在特定目的2和3中研究CYP 1A在这些效应中的作用。
所有三种SA将应用相同的分子技术来修饰CYP 1A
表情这项研究将应用一种强大的器官特异性
基因操作对重大毒理学问题(CYP 1A功能)的影响,
提供深入了解二恶英毒性的重要心血管方面。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ARLEEN B. RIFKIND其他文献
ARLEEN B. RIFKIND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ARLEEN B. RIFKIND', 18)}}的其他基金
Arachidonate Products and CYP1A in Dioxin Toxicity
二恶英毒性中的花生四烯酸产品和 CYP1A
- 批准号:
7636784 - 财政年份:2007
- 资助金额:
$ 46.76万 - 项目类别:
Arachidonate Products and CYP1A in Dioxin Toxicity
二恶英毒性中的花生四烯酸产品和 CYP1A
- 批准号:
7386288 - 财政年份:2007
- 资助金额:
$ 46.76万 - 项目类别:
Arachidonate Products and CYP1A in Dioxin Toxicity
二恶英毒性中的花生四烯酸产品和 CYP1A
- 批准号:
7501910 - 财政年份:2007
- 资助金额:
$ 46.76万 - 项目类别:
Arachidonate Products and CYP1A in Dioxin Toxicity
二恶英毒性中的花生四烯酸产品和 CYP1A
- 批准号:
8092537 - 财政年份:2007
- 资助金额:
$ 46.76万 - 项目类别:
Arachidonate Products and CYP1A in Dioxin Toxicity
二恶英毒性中的花生四烯酸产品和 CYP1A
- 批准号:
7880924 - 财政年份:2007
- 资助金额:
$ 46.76万 - 项目类别:
ARACHIDONATE PRODUCTS IN DIOXIN AND PCB TOXICITY
花生四烯酸产品的二恶英和多氯联苯毒性
- 批准号:
3251067 - 财政年份:1984
- 资助金额:
$ 46.76万 - 项目类别:
ARACHIDONATE PRODUCTS IN DIOXIN AND PCB TOXICITY
花生四烯酸产品的二恶英和多氯联苯毒性
- 批准号:
3251064 - 财政年份:1984
- 资助金额:
$ 46.76万 - 项目类别:
ARACHIDONATE PRODUCTS IN DIOXIN AND PCB TOXICITY
花生四烯酸产品的二恶英和多氯联苯毒性
- 批准号:
3251062 - 财政年份:1984
- 资助金额:
$ 46.76万 - 项目类别:
相似海外基金
Mechanisms of Pro-Resolving Mediators in Periodontal Regeneration
牙周再生中促溶解介质的机制
- 批准号:
10764989 - 财政年份:2023
- 资助金额:
$ 46.76万 - 项目类别:
Oxidative Lipidomics in Pediatric Traumatic Brain Injury
氧化脂质组学在小儿创伤性脑损伤中的应用
- 批准号:
10844023 - 财政年份:2023
- 资助金额:
$ 46.76万 - 项目类别:
Resolution of inflammation and atrial fibrillation
炎症和心房颤动的解决
- 批准号:
10679718 - 财政年份:2023
- 资助金额:
$ 46.76万 - 项目类别:
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity
剖析花生四烯酸代谢途径在 PM 诱导的心脏代谢毒性的消退与进展中的作用
- 批准号:
10716093 - 财政年份:2023
- 资助金额:
$ 46.76万 - 项目类别:
A Novel Neuroprotectant to Reduce Ischemic Injury
一种减少缺血性损伤的新型神经保护剂
- 批准号:
10576568 - 财政年份:2023
- 资助金额:
$ 46.76万 - 项目类别:
Mechanisms regulating the biosynthesis and signaling of oxylipins
氧脂素生物合成和信号传导的调节机制
- 批准号:
10710733 - 财政年份:2023
- 资助金额:
$ 46.76万 - 项目类别:
Lipid Receptor GPR31 as a Target for Anti-Thrombotic and Stroke Therapy
脂质受体 GPR31 作为抗血栓和中风治疗的靶点
- 批准号:
10603440 - 财政年份:2023
- 资助金额:
$ 46.76万 - 项目类别:
Lipid peroxidation- and pyroptosis-induced tissue factor activation in pathogen-induced blood coagulation
病原体诱导的血液凝固中脂质过氧化和焦亡诱导的组织因子激活
- 批准号:
10571353 - 财政年份:2023
- 资助金额:
$ 46.76万 - 项目类别:
Novel redox mechanisms of oxygenated phospholipids in chronic and diabetic kidney disease
慢性和糖尿病肾病中含氧磷脂的新氧化还原机制
- 批准号:
10752954 - 财政年份:2023
- 资助金额:
$ 46.76万 - 项目类别:
Glutathionylated Products of Radical-Induced Lipid Oxidation in Inflammatory Disease
炎症性疾病中自由基诱导的脂质氧化的谷胱甘肽化产物
- 批准号:
10736332 - 财政年份:2023
- 资助金额:
$ 46.76万 - 项目类别: